7.27
price down icon10.02%   -0.81
after-market Handel nachbörslich: 7.77 0.50 +6.88%
loading

Finanzdaten der 89 Bio Inc-Aktie (ETNB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
39.00%
57.28
41.21 39.34 42.13 28.52
Interest Income/Expense
0.35%
0.863
0.866 0.959 0.894 2.075
Operating Income/Loss
39.00%
-57.28
-41.21 -39.34 -42.13 -28.52
Income/Loss From Continuing Operations Before Tax
41.84%
-51.58
-36.37 -34.73 -38.39 -28.84
Income Tax Expense/Benefit
0.097
- - - -
Income/Loss From Continuing Operations After Tax
28.45%
-51.68
-40.23 -34.73 -38.39 -28.84
Net Income/Loss
28.45%
-51.68
-40.23 -34.73 -38.39 -28.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,886%
95.85
3.21 76.34 74.13 53.17
Diluted Average Shares
2,886%
95.85
3.21 76.34 74.13 53.17
Basic Earnings Per Share
8.00%
-0.54
-0.50 -0.45 -0.52 -0.54
Diluted Earnings Per Share
8.00%
-0.54
-0.50 -0.45 -0.52 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):